Publication year |
Reference number |
Location |
Study type |
Setting |
Infection type |
Antibiotic Compared with |
Duration(FSM, ABX) |
Number of patients |
Clinical Outcome |
Microbiological Oucome |
FSM |
ABX |
FSM |
ABX |
2010 |
31 |
Turkey |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Ciprofloxacin |
1, 5 |
142 |
62/77 |
52/65 |
64/77 |
51/65 |
1999 |
26 |
USA |
randomized double blinded trial |
Multi center |
Uncomplicated UTIs |
Nitrofurantoin |
1, 7 |
749 |
207/229 |
193/217 |
146/168 |
127/157 |
2013 |
42 |
Spain |
randomized, single-blind design |
Multi center |
Uncomplicated UTIs |
Ciprofloxacin |
2, 3 |
118 |
32/37 |
32/39 |
23/37 |
23/39 |
1998 |
40 |
UK |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
TMP |
1, 5 |
547 |
139/195 |
69/96 |
147/204 |
70/96 |
1994 |
45 |
Jerusalem |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Cephalexin |
1, 5 |
130 |
53/58 |
49/54 |
53/58 |
45/54 |
1990 |
27 |
Netherlands |
randomized, double-blind design |
Hospital |
Uncomplicated UTIs |
Norfloxacin |
1, 7 |
158 |
55/60 |
48/50 |
60/61 |
48/50 |
2018 |
38 |
Europe |
randomized, single-blind design |
Multi center |
Uncomplicated UTIs |
Nitrofurantoin |
1, 5 |
513 |
139/241 |
171/244 |
103/163 |
129/175 |
1991 |
34 |
France |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Norfloxacin |
1, 5 |
63 |
NA |
NA |
22/30 |
21/27 |
1990 |
41 |
USA |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Amoxycillin |
1, 1 |
158 |
NA |
NA |
52/65 |
40/56 |
1987 |
39 |
Italy |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Pipemidic acid |
1, 7 |
51 |
NA |
NA |
17/24 |
19/27 |
1990 |
44 |
Belguim |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Norfloxacin |
1, 3 |
32 |
NA |
NA |
14/16 |
14/16 |
1990 |
32 |
UK |
randomized, single-blind design |
Hospital |
Acute UTI |
Amoxicillin/clavulanic acid |
1. 5 |
141 |
NA |
NA |
28/33 |
21/29 |
1990 |
36 |
Italy |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Norfloxacin |
1, 7 |
60 |
NA |
NA |
23/30 |
22/30 |
1995 |
30 |
France |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Pefloxacin |
1, 1 |
57 |
NA |
NA |
26/29 |
25/28 |
1990 |
39 |
France |
randomized, single-blind design |
Multi center |
Uncomplicated UTIs |
Pipemidic acid |
1, 5 |
386 |
122/146 |
130/143 |
122/146 |
130/143 |
1990 |
43 |
Italy |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Netilmicin |
1, 1 |
135 |
NA |
NA |
57/71 |
52/64 |
2009 |
35 |
Spain |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Amoxicillin-clavulanate |
1, 7 |
109 |
NA |
NA |
42/53 |
45/56 |
2010 |
31 |
Turkey |
randomized, single-blind design |
Hospital |
Uncomplicated UTIs |
Ciprofloxacin |
1, 5 |
142 |
64/77 |
53/65 |
64/77 |
51/65 |
1990 |
37 |
UK |
randomized, double-blind design |
Hospital |
Uncomplicated UTIs |
Trimethoprim |
1, 1 |
51 |
NA |
NA |
17/22 |
12/017 |
1990 |
33 |
Italy |
randomized, single-blind design |
Multi center |
Uncomplicated UTIs |
Cotrimoxazole |
1, 3 |
36 |
NA |
NA |
17/19 |
13/17 |